A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis
NCT06906900
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Spinal Metastasis
Interventions
DEVICE:
TTF-200M and TTF-200A systems
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]